Aprela® — the making of a new pregnant mare’s urine drug

Part 1 of a Special Report by Jane Allin October 3, 2013 looms as the harbinger of foreboding news for PMU mares and their foals. This is the day that the U.S. Food and Drug Administration (FDA) will make a decision whether or not to approve Ligand Pharmaceutical’s dual-acting drug Aprela® for the treatment of… Continue reading Aprela® — the making of a new pregnant mare’s urine drug